Elsevier Inc.

SHERPA: Unknown

People

  1. Derkach
    Derkach
  2. Giralt
    Giralt
  3. Hassoun
    Hassoun
  4. Hultcrantz
    Hultcrantz
  5. Iyengar
    Iyengar
  6. Korde
    Korde
  7. Lesokhin
    Lesokhin
  8. Mailankody
    Mailankody
  9. Shah
    Shah
  10. Tan
    Tan

Groups

  1. Biostatistics Service (4)
  2. Breast Medicine Service (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. Epidemiology and Biostatistics (4)
  6. Executive Committee, Center for Hematologic Malignancies (4)
  7. Hematologic Malignancies, Division of (4)
  8. Population Sciences Research Program (4)
  9. Sloan Kettering Institute Postdocs (4)
  10. Solid Tumor Oncology Division (4)
Search Within
  1. "Breast Medicine Service"
  2. "Executive Committee, Center for Hematologic Malignancies"
  3. "Survivorship Research"
Formats
  1. Meeting Abstract (4)
Groups
  1. Biostatistics Service (4)
  2. Breast Medicine Service (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. Epidemiology and Biostatistics (4)
  6. Executive Committee, Center for Hematologic Malignancies (4)

More Groups

People
  1. Alexander Lesokhin (3)
  2. Andriy Derkach (3)
  3. Carlyn Rose Tan (3)
  4. Hani Hassoun (3)
  5. Malin Hultcrantz (3)
  6. Marcel Van Den Brink (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2017 (1)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save